$6.99
0.26[3.86%]
At close: Apr 26
$6.99
0[0.00%]
After Hours: 4:20PM EDT
Definitive Healthcare
(NASDAQ:DH)Definitive Healthcare Stock (NASDAQ:DH), Analyst Ratings, Price Targets, Predictions
Definitive Healthcare Corp has a consensus price target of $12.7, established from looking at the 46 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Canaccord Genuity, and Stifel on March 1, 2024, February 29, 2024, and January 17, 2024. With an average price target of $10.67 between Barclays, Canaccord Genuity, and Stifel, there's an implied 52.60% upside for Definitive Healthcare Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Canaccord Genuity
Stifel
Needham
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Definitive Healthcare
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/01/2024 | DH | Buy Now | Definitive Healthcare | $6.99 | 57.37% | Barclays | Saket Kalia | $10 → $11 | Maintains | Equal-Weight | Get Alert |
| 02/29/2024 | DH | Buy Now | Definitive Healthcare | $6.99 | 43.06% | Canaccord Genuity | David Hayes | $9 → $10 | Maintains | Hold | Get Alert |
| 01/17/2024 | DH | Buy Now | Definitive Healthcare | $6.99 | 57.37% | Stifel | David Grossman | $12 → $11 | Maintains | Buy | Get Alert |
| 01/17/2024 | DH | Buy Now | Definitive Healthcare | $6.99 | — | Needham | Ryan MacDonald | — | Downgrade | Buy → Hold | Get Alert |
| 01/05/2024 | DH | Buy Now | Definitive Healthcare | $6.99 | 43.06% | Canaccord Genuity | David Hayes | → $10 | Downgrade | Buy → Hold | Get Alert |
| 11/03/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 35.91% | Morgan Stanley | Craig Hettenbach | $15.5 → $9.5 | Maintains | Overweight | Get Alert |
| 08/16/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 50.21% | Goldman Sachs | Kash Rangan | $17 → $10.5 | Maintains | Neutral | Get Alert |
| 08/15/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 71.67% | Canaccord Genuity | David Hayes | $13 → $12 | Maintains | Buy | Get Alert |
| 08/15/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 114.59% | Morgan Stanley | Craig Hettenbach | $17 → $15 | Maintains | Overweight | Get Alert |
| 08/15/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 50.21% | B of A Securities | Allen Lutz | $12 → $10.5 | Maintains | Neutral | Get Alert |
| 08/15/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 114.59% | Needham | Ryan MacDonald | → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 114.59% | Needham | Ryan MacDonald | → $15 | Reiterates | Buy → Buy | Get Alert |
| 07/24/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 85.98% | Baird | Vikram Kesavabhotla | → $13 | Downgrade | Outperform → Neutral | Get Alert |
| 06/16/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 114.59% | Needham | Ryan MacDonald | → $15 | Reiterates | → Buy | Get Alert |
| 05/08/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 43.06% | Barclays | Saket Kalia | $11 → $10 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 57.37% | B of A Securities | Allen Lutz | → $11 | Maintains | Neutral | Get Alert |
| 05/05/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 71.67% | Credit Suisse | Jonathan Yong | $15 → $12 | Maintains | Neutral | Get Alert |
| 05/05/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | 114.59% | Needham | Ryan MacDonald | → $15 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | DH | Buy Now | Definitive Healthcare | $6.99 | — | William Blair | Ryan Daniels | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Definitive Healthcare (DH)?
The latest price target for Definitive Healthcare (NASDAQ: DH) was reported by Barclays on March 1, 2024. The analyst firm set a price target for $11.00 expecting DH to rise to within 12 months (a possible 57.37% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Definitive Healthcare (DH)?
The latest analyst rating for Definitive Healthcare (NASDAQ: DH) was provided by Barclays, and Definitive Healthcare maintained their equal-weight rating.
When was the last upgrade for Definitive Healthcare (DH)?
The last upgrade for Definitive Healthcare Corp happened on February 24, 2022 when Canaccord Genuity raised their price target to $28. Canaccord Genuity previously had a hold for Definitive Healthcare Corp.
When was the last downgrade for Definitive Healthcare (DH)?
The last downgrade for Definitive Healthcare Corp happened on January 17, 2024 when Needham changed their price target from N/A to N/A for Definitive Healthcare Corp.
When is the next analyst rating going to be posted or updated for Definitive Healthcare (DH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Definitive Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Definitive Healthcare was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.
Is the Analyst Rating Definitive Healthcare (DH) correct?
While ratings are subjective and will change, the latest Definitive Healthcare (DH) rating was a maintained with a price target of $10.00 to $11.00. The current price Definitive Healthcare (DH) is trading at is $6.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.